Press Releases
10 January 2020
BOULDER, Colo., Jan. 10, 2020 /PRNewswire/ -- ArcherDX, Inc. today announced a non-exclusive, multi-year partnership with Illumina, Inc. (NASDAQ: ILMN) intended to broaden access of next generation sequencing (NGS)-based oncology testing, including companion diagnostics for therapeutic selection, personalized monitoring, and recurrence surveillance IVD tests, upon F
Read more...10 January 2020
AUSTIN, Texas, Jan. 10, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the closing of the acquisition of the epigenetic reagent company Octamer GmbH ("Octamer") by its subsidiary Belgian Volition SPRL for approximately $725,000, consisting of cash and shares of restricted common stock of Volition.
Read more...RhoVac Receives Approval in Germany and Belgium to Start Clinical Phase IIb Study in Prostate Cancer
10 January 2020
STOCKHOLM, Jan. 10, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on 10th January 2020, that the company has received approval from Beligian FAMHP (Federal Agency for Medicines and Health Products) and German Federal Institute for Vaccines and Biomedicines for starting the clinical phase IIb study in prostate cancer, a multicenter study en
Read more...10 January 2020
WILMINGTON, Del., Jan. 10, 2020 /PRNewswire/ -- ChristianaCare, one of the most dynamic health systems in the mid-Atlantic region, and GoHealth Urgent Care, one of the nation's fastest-growing urgent care companies, today announced that they have entered into a new partnership to operate ChristianaCare's five medical aid units and establish a network of new urgent c
Read more...10 January 2020
REDWOOD CITY, Calif., Jan. 10, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it will host and webcast an investor briefing at the North American Neuromodulation Society (NANS 2020) in Las Vegas
Read more...10 January 2020
TARRYTOWN, N.Y., Jan. 10, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2019 financial and operating results on Thursday, February 6, 2020, before the U.S. financial markets open. The Company will host a confer
Read more...MANSFIELD, Mass., Jan. 10, 2020 /PRNewswire/ -- Transplant Genomics, Inc. ("TGI"), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by genomics, today announced that Dr. John Holman has joined the Company as VP Medical Affairs. Dr. Holman comes to TGI having ser
Read more...10 January 2020
TOKYO, Jan. 10, 2020 /PRNewswire/ -- HEALIOS K.K. ("Healios") has been moving forward with efforts to create next generation immunotherapies for solid tumors by combining its iPS cell and gene editing technology expertise. In this notice we are disclosing that we have decided to add the development of allogeneic, iPS cell derived gene-modified natural killer
Read more...CHARLOTTE, N.C., Jan. 10, 2020 /PRNewswire/ -- Acuity Healthcare, the country's only Employee Owned Hospital Company and a leader in long-term acute care, today announced that Executive Vice President Rick Cassady, CPA, MBA, has been promoted to Chief Operating Officer, effective immediately.
Read more...LAVAL, QC, Jan. 10, 2020 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (Nasdaq: NEPT) (TSX: NEPT), a health and wellness company focused on extraction, purification and formulation of cannabinoids, would like to provide the following corporate updates and outlook ahead of its participation at the Annual ICR Conference in Orlando, Florida
Read more...
